In our study, ATR and TOP1 inhibitors, trigger the expression of genes encoding type I IFN signaling and pro‐inflammatory cytokines/chemokines in a STING‐low SCLC cell line (H446). The gene discussed is STING1; the disease is small cell lung carcinoma.